Learn / DNA
NYSE: DNA
Ginkgo Bioworks Holdings (DNA) stock, explained like you're 5
Ginkgo Bioworks Holdings trades on the New York Stock Exchange under the ticker DNA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 836 million dollars.
- Ticker
- DNA
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 836 million dollars
Is Ginkgo Bioworks Holdings a small, medium or large cap company?
No. Ginkgo Bioworks Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 836 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Ginkgo Bioworks Holdings makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DNA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand (Yahoo Finance)
- Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Officer Steven P. Coen proposes selling 2,403 Ginkgo Bioworks (NYSE: DNA) shares. (Stock Titan)
- ‘We have more in our DNA’: Knorr Bremse looks beyond rolling stock (Railway Gazette International)
- Responsive Playbooks and the DNA Inflection (Stock Traders Daily)
Follow DNA in your daily brief
Each trading day at 5 PM ET we post what happened to Ginkgo Bioworks Holdings and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DNA
Questions about Ginkgo Bioworks Holdings stock
What does Ginkgo Bioworks Holdings do?
Ginkgo Bioworks Holdings trades on the New York Stock Exchange under the ticker DNA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 836 million dollars.
What is the ticker symbol for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings trades under the ticker DNA on the New York Stock Exchange.
What is Ginkgo Bioworks Holdings's market cap?
Ginkgo Bioworks Holdings is a small cap stock with a market cap of about 836 million dollars.
How does Ginkgo Bioworks Holdings make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DNA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DNA stock every day?
Add DNA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.